• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-(3-烷基-1,2,4-恶二唑-5-基)-1,4,5,6-四氢嘧啶作为M1毒蕈碱受体激动剂的设计、合成及神经化学评价

Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.

作者信息

Dunbar P G, Durant G J, Fang Z, Abuh Y F, el-Assadi A A, Ngur D O, Periyasamy S, Hoss W P, Messer W S

机构信息

Department of Medicinal and Biological Chemistry, College of Pharmacy, University of Toledo, Ohio 43606.

出版信息

J Med Chem. 1993 Apr 2;36(7):842-7. doi: 10.1021/jm00059a008.

DOI:10.1021/jm00059a008
PMID:8464038
Abstract

A series of 5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines+ ++ (7a-h) was synthesized for biological evaluation as selective agonists for M1 receptors coupled to phosphoinositide (PI) metabolism in the central nervous system. Each ligand bound with high affinity to muscarinic receptors from rat brain as measured by inhibition of [3H]-(R)-quinuclidinyl benzilate ([3H]-(R)-QNB) binding. 5-(3-Methyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine+ ++ trifluoroacetate (CDD-0098-J;7a) displayed high affinity (IC50 = 2.7 +/- 0.69 microM) and efficacy at muscarinic receptors coupled to PI metabolism in the rat cortex and hippocampus. Increasing the length of the alkyl substituent increased affinity for muscarinic receptors yet decreased activity in PI turnover assays. The hippocampal PI response of 7a was blocked by lower concentrations of pirenzepine (8) or by higher concentrations of either AF-DX 116 (9) or p-fluorohexahydrosiladifenidol (10), suggesting that at low concentrations 7a selectively stimulates PI turnover through M1 receptors.

摘要

合成了一系列5-(3-烷基-1,2,4-恶二唑-5-基)-1,4,5,6-四氢嘧啶(7a - h),用于作为中枢神经系统中与磷酸肌醇(PI)代谢偶联的M1受体的选择性激动剂进行生物学评价。通过抑制[3H]-(R)-喹核醇苯甲酸酯([3H]-(R)-QNB)结合测定,每个配体都与大鼠脑毒蕈碱受体具有高亲和力。5-(3-甲基-1,2,4-恶二唑-5-基)-1,4,5,6-四氢嘧啶三氟乙酸盐(CDD - 0098 - J;7a)在大鼠皮质和海马体中与PI代谢偶联的毒蕈碱受体上显示出高亲和力(IC50 = 2.7 +/- 0.69 microM)和效能。增加烷基取代基的长度增加了对毒蕈碱受体的亲和力,但降低了PI周转试验中的活性。7a的海马体PI反应被较低浓度的哌仑西平(8)或较高浓度的AF - DX 116(9)或对氟六氢硅二苯胺(10)阻断,表明在低浓度下7a通过M1受体选择性刺激PI周转。

相似文献

1
Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.5-(3-烷基-1,2,4-恶二唑-5-基)-1,4,5,6-四氢嘧啶作为M1毒蕈碱受体激动剂的设计、合成及神经化学评价
J Med Chem. 1993 Apr 2;36(7):842-7. doi: 10.1021/jm00059a008.
2
Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.2-氨基-5-(烷氧羰基)-3,4,5,6-四氢吡啶和2-氨基-5-(烷氧羰基)-1,4,5,6-四氢嘧啶作为M1毒蕈碱受体激动剂的设计、合成及神经化学评价
J Med Chem. 1994 Aug 19;37(17):2774-82. doi: 10.1021/jm00043a016.
3
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.1,4,5,6-四氢嘧啶和2-氨基-3,4,5,6-四氢吡啶衍生物作为选择性M1激动剂的合成及生物学特性研究
J Med Chem. 1997 Apr 11;40(8):1230-46. doi: 10.1021/jm960467d.
4
Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.2-(3-取代-1,2,4-恶二唑-5-基)-8-甲基-8-氮杂双环[3.2.1]辛烷和2α-(3-取代-1,2,4-恶二唑-5-基)-8-甲基-8-氮杂双环[3.2.1]辛-2-烯作为潜在毒蕈碱激动剂的合成
Pharm Res. 1992 Nov;9(11):1474-9. doi: 10.1023/a:1015871131913.
5
Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.3-(3-烷基-1,2,4-恶二唑-5-基)-1,2,5,6-四氢吡啶类毒蕈碱型胆碱能激动剂和拮抗剂。合成及构效关系
J Med Chem. 1991 Feb;34(2):687-92. doi: 10.1021/jm00106a033.
6
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .新型功能性M1选择性毒蕈碱激动剂。3-(1,2,5-噻二唑基)-1,2,5,6-四氢-1-甲基吡啶的合成与构效关系
J Med Chem. 1992 Jun 12;35(12):2274-83. doi: 10.1021/jm00090a019.
7
Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.大鼠脑中选择性毒蕈碱受体拮抗剂结合的区域差异:与最低能量构象的比较。
J Med Chem. 1989 Jun;32(6):1164-72. doi: 10.1021/jm00126a004.
8
Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.大鼠脑中毒蕈碱结合位点M1、M2以及非M1、非M2亚型的区域分布
J Pharmacol Exp Ther. 1990 Dec;255(3):1148-57.
9
Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
Biochem Pharmacol. 1988 Jun 15;37(12):2437-43. doi: 10.1016/0006-2952(88)90371-1.
10
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.[3H]哌仑西平和(-)-[3H]东莨菪碱与大鼠大脑皮质及心脏毒蕈碱胆碱能位点的结合。II. 拮抗剂与假定毒蕈碱亚型结合的特性及调节
J Pharmacol Exp Ther. 1986 May;237(2):419-27.

引用本文的文献

1
The Partial M Muscarinic Cholinergic Receptor Agonist, CDD-0102A, Differentially Modulates Glutamate Efflux in Striatal Subregions during Stereotyped Motor Behavior in the BTBR Mouse Model of Autism.部分 M 毒蕈碱型乙酰胆碱受体激动剂 CDD-0102A 在自闭症 BTBR 小鼠刻板运动行为期间对纹状体亚区谷氨酸外排的差异调节。
ACS Chem Neurosci. 2023 Aug 2;14(15):2699-2709. doi: 10.1021/acschemneuro.3c00260. Epub 2023 Jul 11.
2
Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide.4,6-二甲基-2-硫代吡啶-3-甲酰胺新型1,3,4-恶二唑衍生物的生物学评价及分子对接研究
Int J Mol Sci. 2022 Jan 4;23(1):549. doi: 10.3390/ijms23010549.
3
Syntheses of 3,4- and 1,4-dihydroquinazolines from 2-aminobenzylamine.
由2-氨基苄胺合成3,4-二氢喹唑啉和1,4-二氢喹唑啉。
Beilstein J Org Chem. 2017 Jul 27;13:1470-1477. doi: 10.3762/bjoc.13.145. eCollection 2017.
4
The selective M1 muscarinic cholinergic agonist CDD-0102A enhances working memory and cognitive flexibility.选择性 M1 毒蕈碱型乙酰胆碱能激动剂 CDD-0102A 增强工作记忆和认知灵活性。
J Pharmacol Exp Ther. 2012 Mar;340(3):588-94. doi: 10.1124/jpet.111.187625. Epub 2011 Dec 1.
5
The utility of muscarinic agonists in the treatment of Alzheimer's disease.毒蕈碱激动剂在阿尔茨海默病治疗中的效用。
J Mol Neurosci. 2002 Aug-Oct;19(1-2):187-93. doi: 10.1007/s12031-002-0031-5.